Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment

Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest malignancies worldwide, is characteristic of the tumor microenvironments (TME) comprising numerous fibroblasts and immunosuppressive cells. Conventional therapies for PDAC are often restricted by limited drug delivery efficiency, immunosu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jinlu, Wu, Wenbi, Zhu, Qing, Zhu, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610350/
https://www.ncbi.nlm.nih.gov/pubmed/37896181
http://dx.doi.org/10.3390/pharmaceutics15102421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610350/
https://www.ncbi.nlm.nih.gov/pubmed/37896181
http://dx.doi.org/10.3390/pharmaceutics15102421

Ejemplares similares